Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Systemic Sclerosis and Related Diseases.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
Homozygous <i>GDF2</i> nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an “HHT‐like” syndrome in children
Respiratory follow-up of patients with COVID-19 pneumonia
Bayesian Inference Associates Rare <i>KDR</i> Variants With Specific Phenotypes in Pulmonary Arterial Hypertension
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
Definitions and Diagnosis of Pulmonary Hypertension
P157 Hepatocyte growth factor concentration correlates with haemodynamic severity in connective tissue disease-associated pulmonary arterial hypertension
Reduced MicroRNA-150 Is Associated with Poor Survival in Pulmonary Arterial Hypertension